2026 Regulatory Changes: What eQMS Users Need to Know

Several long-anticipated regulatory updates are finally coming into force, and together they reshape how organizations are expected to manage quality, risk, and documentation. For teams using an electronic Quality Management System (eQMS), these changes directly impact how quality processes are structured, executed, and inspected. The good news? A well-implemented eQMS can make these transitions far more manageable and knowing what’s changing will allow teams to prepare accordingly. 

2026 Regulatory Changes

FDA QMSR: A New Era for U.S. Medical Device Quality Systems 

The most significant update for medical device manufacturers is the FDA’s Quality Management System Regulation (QMSR) becomes effective on February 2, 2026. This rule replaces the long-standing Quality System Regulation (21 CFR Part 820) and formally aligns U.S. requirements with ISO 13485:2016. 

QMSR shifts the regulatory mindset toward international harmonization and risk-based quality management. Concepts like lifecycle risk management, supplier controls, and design documentation are now expected to be integrated and consistent across global markets. 

This means that eQMS solutions need to do more than store procedures, but rather clearly map processes to ISO 13485 clauses including support end-to-end risk management and maintaining inspection-ready records. Change management, CAPA, internal audits, and supplier quality all need to be connected, traceable, and easy to demonstrate during FDA inspections under the new framework. Organizations that already use their eQMS as the “single source of truth” for quality data are at a major advantage here. 

EUDAMED Goes Mandatory in the EU 

While the FDA is modernizing its quality regulation, the European Union is finalizing its digital infrastructure. Starting May 28, 2026, core EUDAMED modules become mandatory for medical device and IVD manufacturers under the EU MDR and IVDR. 

EUDAMED introduces centralized registration and transparency requirements across the EU, including actor registration, UDI/device registration, notified body certificates, and post-market surveillance data. From an eQMS perspective, this creates a strong need for structured data management. Device information, technical documentation references, vigilance activities, and post-market surveillance outputs all need to align with what is submitted to EUDAMED. An effective eQMS helps by standardizing how this information is captured internally, ensuring version control, and maintaining clear links between regulatory data and quality processes like complaint handling and corrective actions. 

In practice, teams using an eQMS to manage MDR-aligned workflows will find EUDAMED compliance far less disruptive than those relying on disconnected tools and spreadsheets. 

ISO Standards Continue to Evolve 

Beyond formal regulations, quality standards are also moving forward. An updated version of ISO 9001 is expected later in 2026, with stronger emphasis on leadership involvement, risk-based thinking, digital systems, and organizational resilience. 

While ISO 9001 may not be a regulatory requirement for all industries, it strongly influences how regulators and auditors assess quality maturity. Expectations around management review, continuous improvement, and data-driven decision-making continue to rise. 

eQMS platforms play a critical role here by enabling structured management reviews, trend analysis, audit tracking, and performance monitoring — all of which support compliance not just with the letter of the standard, but with its intent. 

The Growing Impact of AI and Software Regulation 

Another emerging theme in 2026 is the regulation of software and AI-enabled systems, particularly in the EU. As provisions of the EU AI Act begin to come into force, organizations developing or using high-risk AI systems, including AI in medical or regulated software, will be expected to implement formal quality and risk controls. 

While not traditionally viewed as “QMS regulations,” these requirements rely heavily on documented processes, risk assessments, change control, and post-deployment monitoring. In other words, they land squarely in the territory of quality management. 

An eQMS that already supports software lifecycle documentation, risk management, and traceability can serve as the backbone for meeting these expectations without needing to taxingly reinvent your quality system. 

What This Means for eQMS Users 

Taken together, the 2026 regulatory updates point to a clear direction: regulators expect quality systems to be integrated, digital, and proactive. Compliance has evolved to include demonstrating control, consistency, and insight across the entire product lifecycle. 

For eQMS users, this is an opportunity. By configuring workflows to align with ISO 13485, MDR/IVDR, and emerging software regulations, organizations can turn regulatory change into operational clarity. Instead of reacting to audits and deadlines, teams can use their eQMS to stay continuously compliant, inspection-ready, and scalable across regions. 

This year may bring big regulatory shifts, but for organizations that invest in using their eQMS effectively, it doesn’t have to bring big disruption.